Querfeld C - Search Results

1

Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia.

Brammer JE, Ballen K, Sokol L, Querfeld C, Nakamura R, Mishra A, McLaughlin EM, Feith D, Azimi N, Waldmann TA, Tagaya Y, Loughran T. Brammer JE, et al. Among authors: querfeld c. Blood. 2023 Oct 12;142(15):1271-1280. doi: 10.1182/blood.2022017643. Blood. 2023. PMID: 37352612 Free PMC article. Clinical Trial.

2

Normal human primary fibroblasts undergo apoptosis in three-dimensional contractile collagen gels.

Fluck J, Querfeld C, Cremer A, Niland S, Krieg T, Sollberg S. Fluck J, et al. Among authors: querfeld c. J Invest Dermatol. 1998 Feb;110(2):153-7. doi: 10.1046/j.1523-1747.1998.00095.x. J Invest Dermatol. 1998. PMID: 9457911 Free article.

3

CD30-Positive Lymphoproliferative Disorders.

Nikolaenko L, Zain J, Rosen ST, Querfeld C. Nikolaenko L, et al. Among authors: querfeld c. Cancer Treat Res. 2019;176:249-268. doi: 10.1007/978-3-319-99716-2_12. Cancer Treat Res. 2019. PMID: 30596222

4

Phase II trial of subcutaneous injections of human recombinant interleukin-2 for the treatment of mycosis fungoides and Sézary syndrome.

Querfeld C, Rosen ST, Guitart J, Rademaker A, Foss F, Gupta R, Kuzel TM. Querfeld C, et al. J Am Acad Dermatol. 2007 Apr;56(4):580-3. doi: 10.1016/j.jaad.2006.08.067. Epub 2006 Nov 7. J Am Acad Dermatol. 2007. PMID: 17367611 Clinical Trial.

5

Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.

Querfeld C, Khan I, Mahon B, Nelson BP, Rosen ST, Evens AM. Querfeld C, et al. Oncology (Williston Park). 2010 Jun;24(7):574-87. Oncology (Williston Park). 2010. PMID: 20669794 Review.

6

Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma.

Querfeld C, Kuzel TM, Kim YH, Porcu P, Duvic M, Musiek A, Rook AH, Mark LA, Pinter-Brown L, Hamid O, Lin B, Bian Y, Boye M, Day JM, Rosen ST. Querfeld C, et al. Leuk Lymphoma. 2011 Aug;52(8):1474-80. doi: 10.3109/10428194.2011.572265. Epub 2011 Jun 8. Leuk Lymphoma. 2011. PMID: 21649541 Clinical Trial.

7

Multicenter case series of indolent small/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face.

Li JY, Guitart J, Pulitzer MP, Subtil A, Sundram U, Kim Y, Deonizio J, Myskowski PL, Moskowitz A, Horwitz S, Querfeld C. Li JY, et al. Among authors: querfeld c. Am J Dermatopathol. 2014 May;36(5):402-8. doi: 10.1097/DAD.0b013e3182a74c7a. Am J Dermatopathol. 2014. PMID: 24394306

8

Long-term follow-up and management of small and medium-sized CD4⁺ T cell lymphoma and CD8⁺ lymphoid proliferations of acral sites: a multicenter experience.

Virmani P, Jawed S, Myskowski PL, Horwitz S, Skripnik Lucas A, Moskowitz A, Pulitzer M, Zain J, Rosen ST, Querfeld C. Virmani P, et al. Among authors: querfeld c. Int J Dermatol. 2016 Nov;55(11):1248-1254. doi: 10.1111/ijd.13340. Int J Dermatol. 2016. PMID: 27369070 Free PMC article.

9

Successful treatment of recalcitrant, erythroderma-associated pruritus with etanercept.

Querfeld C, Guitart J, Kuzel TM, Rosen S. Querfeld C, et al. Arch Dermatol. 2004 Dec;140(12):1539-40. doi: 10.1001/archderm.140.12.1539. Arch Dermatol. 2004. PMID: 15611443 No abstract available.

10

Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome.

Jawed SI, Busam K, Wang X, Horwitz S, Querfeld C. Jawed SI, et al. Among authors: querfeld c. JAMA Dermatol. 2014 Sep;150(9):1021-3. doi: 10.1001/jamadermatol.2013.10615. JAMA Dermatol. 2014. PMID: 25029560 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters